The obesity treatment drug market is approaching 2 trillion KRW, but despite the risk of blindness, patients are not being informed about potential side effects.
We haven't written up this one. Hankyoreh has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.